Sri Ramakrishna Hospital Ethical Committee was constituted on 9th January 2015. Ethics committee re-registration with DCGI-CDSCO was done on Oct 2026 with a validity period from 9th January 2026 to 8th January 2031 under New Drugs and Clinical Trial Rules 2019 (Registration Number: ECR/690/Inst/TN/2014/RR-26). The committee reviews the proposals for clinical trials (Phase 3 & Phase 4), research studies (Observational and Interventional concerning the safety of subject (patient)
Additionally, the committee received NABH Accreditation on July 30, 2019, for a three-year term, and secured registration with the National Ethics Committee Registry for Biomedical and Health Research (NECRBHR-DHR) on July 7, 2020 (Registration Number: EC/NEW/INST/2020/562).
The Committee members are:
